Mode
Text Size
Log in / Sign up

Meta-analysis finds no benefit of topical antibiotic prophylaxis for endophthalmitis after intravitreal injectionsDo antibiotic eye drops prevent dangerous infections after eye injections?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that routine topical antibiotic prophylaxis may not reduce endophthalmitis risk after intravitreal injections.

This systematic review and meta-analysis examined the efficacy of topical antibiotic prophylaxis in preventing endophthalmitis following intravitreal injections. The analysis included data from 5,834,932 injections (3,426,671 with prophylaxis and 2,408,261 without) across multiple studies, though specific study designs and settings were not reported. The primary comparison was between patients receiving topical antibiotic prophylaxis and those receiving no antibiotic prophylaxis.

For the overall analysis, there was no significant difference in endophthalmitis incidence between the prophylaxis and no-prophylaxis groups (P = 0.09). Absolute numbers and effect sizes for this comparison were not reported. In a subgroup analysis specifically examining anti-vascular endothelial growth factor (anti-VEGF) injections, antibiotic prophylaxis was associated with a significantly higher risk of endophthalmitis, with an odds ratio of 1.56 (95% CI, 1.03-2.36).

Safety and tolerability data were not reported. The authors note that the evidence for the subgroup finding of increased risk is of very low certainty, which is a key limitation. The practice relevance is that routine use of antibiotic prophylaxis for intravitreal injections appears unwarranted, though clinicians should interpret the subgroup finding with caution due to the evidence quality.

If you or someone you love gets injections in the eye to treat conditions like macular degeneration, you know how scary the risk of infection can be. For years, many doctors have used antibiotic eye drops before these shots, hoping to prevent a rare but devastating infection called endophthalmitis. But does this routine step actually help?

A new analysis looked at data from a staggering 5.8 million eye injections. The main finding was clear: overall, using antibiotic drops did not significantly lower the rate of these infections. When researchers dug deeper into one specific and very common type of injection—those using anti-VEGF drugs to treat wet macular degeneration—they saw a signal that was more concerning. In this subgroup, patients who got antibiotic drops appeared to have a higher risk of infection. The analysis calculated this risk as being 56% higher, though the range of possible risk was wide.

It's crucial to understand the limits of this finding. The evidence pointing to a higher risk is considered 'very low-certainty.' This means we can't be sure if the antibiotics are truly causing harm or if other factors in the studies are responsible. The analysis didn't report on side effects from the drops themselves. What this review strongly suggests is that the routine, automatic use of these antibiotic drops is not justified by the evidence we have.

What this means for you:
Routine antibiotic eye drops before injections don't prevent infection and may even increase risk for some.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
PURPOSE: Endophthalmitis is a rare but severe complication of intravitreal injections that can result in significant vision loss. This systematic review and meta-analysis aimed to evaluate the efficacy of topical antibiotic prophylaxis in reducing endophthalmitis incidence, a topic of ongoing controversy and varied clinical practice worldwide. METHODS: A systematic review and meta-analysis was conducted by searching PubMed, Embase, Cochrane, and Web of Science through July 2025. Studies comparing endophthalmitis incidence in intravitreal injections with and without antibiotic prophylaxis were included; reviews, case reports, and studies lacking outcome data were excluded. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the risk of bias in nonrandomized studies of interventions tool. Data were pooled using a random-effects model. The protocol was registered in PROSPERO (CRD420251102460). RESULTS: Twenty-two studies encompassing 5,834,932 intravitreal injections (3,426,671 with prophylaxis and 2,408,261 without) were included. Overall, no significant difference in endophthalmitis incidence was observed between groups ( P = 0.09). However, a subgroup analysis of antivascular endothelial growth factor injections showed a significantly higher risk of endophthalmitis in the antibiotic group (odds ratio, 1.56; 95% confidence interval, 1.03-2.36; I 2 = 31%; very low-certainty evidence). CONCLUSION: Topical antibiotic prophylaxis was not associated with a reduced risk of endophthalmitis and may increase the risk in patients receiving antivascular endothelial growth factor intravitreal injections. These findings suggest that the routine use of antibiotic prophylaxis for these injections is unwarranted.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.